Public Reporting

Find a Provider

ACO Name and Location:

St. Rose Quality Care Network, LLC
3001 St. Rose Parkway
Henderson, NV 89052

 

ACO Primary Contact:

Primary Contact Name

Margie Roper

Primary Contact Phone Number

(702) 616-5719

Primary Contact Email Address

Margie.Roper @DignityHealth.org

Organizational Information:

  • ACO Participants
  • ACO Participants

    ACO Participant in Joint Venture

    Ensign Family Medicine Llc

    N

    Scott Selco, Professional Corporation

    N

    Dara J. Welborn, M.D., P.C.

    N

    S and S Kim Group, PC

    N

    Brian E. Lee, M.D., LTD

    N

    Sports Medicine Rehabilitation Associates

    N

    Dignity Health Medical Group Nevada, LLC

    N

    Armour, Christensen, Simon, Chtd

    N

    Siena Hills Primary Care, Llc

    N

    Kochy M. Y. Tang, D.O., A Professional Corporation

    N

    Rita B. Chuang MD LLC

    N

  • ACO Governing Body:
  • Member

    Last Name

    First Name

    Title / Position

    Member's Voting Power

    Membership Type

    ACO Participant TIN
    Legal Business
    Name/DBA, if
    Applicable

    Simon

    Irwin

    Chair

    1

    ACO Participant Representative

    Armour, Christensen, Simon, Chartered

    Welborn

    Dara

    Payer Committee Chair

    1

    ACO Participant Representative

    Dara J. Welborn, M.D., P.C.

    Selco

    Scott

    Finance Committee Chair

    1

    ACO Participant Representative

    Scott Selco, Professional Corporation

    Gong

    Robert

    Vice Chair, Quality Committee Chair

    1

    ACO Participant Representative

    Siena Hills Primary Care, LLC

    Flaviano

    Casiano

    1

    ACO Participant Representative

    Sports Medicine Rehabilitation Associates, A Flaviano Professional Corporation

    Harouni

    Rama

    1

    ACO Participant Representative

    Dignity Health Medical Group Nevada, LLC

    Bassett

    Eugene

    Hospital Representative: SVP Nevada Service Area

    1

    Community Stakeholder Representative

    N/A

    Pretzlaff

    Robert

    Hospital Representative: Chief Physician Executive

    1

    Community Stakeholder Representative

    N/A

    Bower

    Joel

    1

    Medicare Beneficiary Representative

    N/A

    Bertoli

    Troy

    1

    ACO Participant Representative

    Dignity Health Medical Group Nevada, LLC

    Venkat

    Raji

    1

    ACO Participant Representative

    Dignity Health Medical Group Nevada, LLC

    Lee

    Brian

    1

    ACO Participant Representative

    Brian E. Lee, M.D., LTD

    Salcedo

    Anna

    Secretary

    1

    ACO Participant Representative

    Dara J. Welborn, M.D., P.C.

  • Key ACO Clinical and Administrative Leadership:
  • Margie Roper

    ACO Executive

    Teresa Hong

    Medical Director

    Dawnese Kindelt

    Compliance Official

    Robert Pretzlaff

    Quality Assurance/Improvement Officer

  • Associated Committees and Committee leadership:
  • Committee Name

    Committee Leader Name and Position

    Payer Committee

    Dr. Dara Welborn, Chair

    Finance Committee

    Dr. Scott Selco, Chair

    Quality Committee

    Dr. Robert Gong, Chair

  • Types of ACO participants, or combinations of participants, that formed the ACO:
  • ACO professionals in a group practice arrangement
    Network of individual practices of ACO professionals
    Partnership or joint venture arrangement between hospitals and ACO professionals

Shared Savings and Losses:

  • Amount of Shared Savings/Losses
  • N/A

  • Shared Savings Distribution
  • N/A

Quality Performance Results:

2016 Quality Performance Results

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

N/A

80.51

ACO-2

CAHPS: How Well Your Providers Communicate

N/A

93.01

ACO-3

CAHPS: Patients' Rating of Provider

N/A

92.25

ACO-4

CAHPS: Access to Specialists

N/A

83.49

ACO-5

CAHPS: Health Promotion and Education

N/A

60.32

ACO-6

CAHPS: Shared Decision Making

N/A

75.40

ACO-7

CAHPS: Health Status/Functional Status

N/A

72.30

ACO-34

CAHPS: Stewardship of Patient Resources

N/A

26.97

ACO-8

Risk-Standardized, All Condition Readmission

N/A

14.70

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

N/A

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

N/A

53.20

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

N/A

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

N/A

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

N/A

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

N/A

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

N/A

82.72

ACO-39

Documentation of Current Medications in the Medical Record

N/A

87.54

ACO-13

Falls: Screening for Future Fall Risk

N/A

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

N/A

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

N/A

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

N/A

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

N/A

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

N/A

53.63

ACO-19

Colorectal Cancer Screening

N/A

61.52

ACO-20

Breast Cancer Screening

N/A

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

N/A

76.79

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

N/A

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

N/A

18.24

ACO-41

Diabetes: Eye Exam

N/A

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

N/A

70.69

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

N/A

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

N/A

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

N/A

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Payment Rule Waivers:

  • No, our ACO does not use the SNF 3-Day Rule Waiver.